BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4413441)

  • 1. Fatal myocardial infarction during thrombosis prophylaxis with warfarin and dextran 70.
    Ro JS; Kluge TH
    Scand J Thorac Cardiovasc Surg; 1974; 8(2):109-14. PubMed ID: 4413441
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticoagulation therapy for prevention of pancreatic graft thrombosis: benefits and risks.
    Tollemar J; Tydén G; Brattström C; Groth CG
    Transplant Proc; 1988 Jun; 20(3):479-80. PubMed ID: 2454522
    [No Abstract]   [Full Text] [Related]  

  • 3. Some observations on the alteration of the adhesiveness of human blood platelets after infusion with low molecular weight dextran.
    Lal HB; Caroli RK; Sengupta D; Basumalik SN; Khan MA; Malik RN; Warrik HP
    J Assoc Physicians India; 1968 Aug; 16(8):523-7. PubMed ID: 5700157
    [No Abstract]   [Full Text] [Related]  

  • 4. Thrombosis prophylaxis with dextran and warfarin in vascular operations.
    Kluge TH; Ro JS; Fretheim B; Stormorken H
    Surg Gynecol Obstet; 1972 Dec; 135(6):941-4. PubMed ID: 5086003
    [No Abstract]   [Full Text] [Related]  

  • 5. Dextran 75 and postoperative phlebitis. Evaluation of dextran 75 in the prophylaxis of postoperative thrombophlebitis, pulmonary embolism, and myocardial infarction.
    Hartshorn JW; Teale SN; Faiz M
    Arch Surg; 1969 Jun; 98(6):694-7. PubMed ID: 4889724
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of prophylaxis on proximal venous thrombus formation after total hip arthroplasty.
    Paiement GD; Schutzer SF; Wessinger SJ; Harris WH
    J Arthroplasty; 1992 Dec; 7(4):471-5. PubMed ID: 1282537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextran in prophylaxis of thrombosis in fractures of the hip.
    Ahlberg A; Nylander G; Robertson B; Cronberg S; Nilsson IM
    Acta Chir Scand Suppl; 1968; 387():83-5. PubMed ID: 5256249
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction in venous thromboembolism by agents affecting platelet function.
    Salzman EW; Harris WH; DeSanctis RW
    N Engl J Med; 1971 Jun; 284(23):1287-92. PubMed ID: 5576438
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrodex prophylaxis in postoperative thrombosis. A prelininary communication.
    Stadil F
    Acta Chir Scand Suppl; 1968; 387():88-90. PubMed ID: 5256251
    [No Abstract]   [Full Text] [Related]  

  • 10. Dextran 70 in prophylaxis of postoperative venous thrombosis. A controlled trial.
    Lambie JM; Barber DC; Dhall DP; Matheson NA
    Br Med J; 1970 Apr; 2(5702):144-5. PubMed ID: 4909450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombosis prevention.
    Sherry S
    N Engl J Med; 1971 Jun; 284(23):1324-6. PubMed ID: 5576445
    [No Abstract]   [Full Text] [Related]  

  • 12. A further trial comparing Dextran 70 with Warfarin in the prophylaxis of postoperative venous thrombosis.
    Davidson AI; Brunt ME; Matheson NA
    Br J Surg; 1972 Apr; 59(4):314. PubMed ID: 5020779
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of warfarin, low-molecular-weight dextran, aspirin, and subcutaneous heparin in prevention of venous thromboembolism following total hip replacement.
    Harris WH; Salzman EW; Athanasoulis C; Waltman AC; Baum S; DeSanctis RW
    J Bone Joint Surg Am; 1974 Dec; 56(8):1552-62. PubMed ID: 4434023
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework.
    Lancet; 1998 Jan; 351(9098):233-41. PubMed ID: 9457092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of dextran-70, warfarin and low-dose heparin for the prophylaxis of thrombo-embolism following total hip replacement.
    Barber HM; Feil EJ; Galasko CS; Edwards DH; Sutton RA; Haynes DW; Bentley G
    Postgrad Med J; 1977 Mar; 53(617):130-3. PubMed ID: 859784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextran-related complications in head and neck microsurgery: do the benefits outweigh the risks? A prospective randomized analysis.
    Disa JJ; Polvora VP; Pusic AL; Singh B; Cordeiro PG
    Plast Reconstr Surg; 2003 Nov; 112(6):1534-9. PubMed ID: 14578781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight dextran in acute myocardial infarction.
    Borchgrevink CF; Enger E
    Br Med J; 1966 Nov; 2(5524):1235-8. PubMed ID: 5917835
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased erythrocyte sedimentation rate following anti-thrombotic treatment with dextrans.
    Ro JS; Kluge T
    Scand J Thorac Cardiovasc Surg; 1971; 5(1):47-50. PubMed ID: 5115431
    [No Abstract]   [Full Text] [Related]  

  • 19. Current concepts of warfarin therapy.
    Peterson CE; Kwaan HC
    Arch Intern Med; 1986 Mar; 146(3):581-4. PubMed ID: 3513725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experiences with antithrombotic effect of postoperatives dextran 70 000 infusions (author's transl)].
    Ott W
    Schweiz Rundsch Med Prax; 1975 Aug; 64(32):1032-4. PubMed ID: 1161750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.